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AntimicrobialAbstract Thiophene analogues of chalcones were synthesized in good yields by condensation of
2-acetylthiophene and salicylaldehydes. Solvent-free Michael addition of cyclohexanone to 2-thie-
nylchalcones devoid of hydroxyl groups yielded 1,5-diketones. The chalcones and 1,5-diketones
were utilised as synthons for ﬂavans, 6H-benzo[c]chromen-6-ones, tetrahydro-2H-chromens, tetra-
hydroquinolines and diazepines. The methods utilised were short and efﬁcient in good yields and
operational simplicity. The synthesized heterocyclic compounds were characterised by IR, NMR
and HR-MS spectral data and screened for their antimicrobial activity against Staphylococcus
aureus, Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa and Candida albicans. The
compounds demonstrated moderate to good antibacterial and antifungal activities. The synthesis
of new heterocyclic compounds with an antimicrobial activity argument this study.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Chalcones are an important group of natural products that
consist of two aromatic rings joined by an a,b-unsaturated
carbonyl system. The a,b-unsaturated carbonyl system enables
chalcones and their heteroanalogs to undergo conjugated addi-
tion reactions in the presence of Lewis acid and basic catalysts
(Al-Jaber et al., 2012; Samshuddin et al., 2012). Literature has
indicated that this reaction has been exploited to obtain
heterocyclic compounds of biological signiﬁcance, such as
pyridines, pyrazoles, pyrimidines, isoxazoles (Azab et al.,2013; Samshuddin et al., 2012), 1,5-benzodiazepines (Al-Jaber
et al., 2012), ﬂavonoids (Bano et al., 2013), thiazines
(Konstantinova et al., 2007) and cyclohexenones (Sreevidya
et al., 2010; Roman, 2004).
The appreciation of chalcone derived heterocyclic com-
pounds’ diverse biological applications and the continuous
application of chalcone derivatives as synthons in organic syn-
thesis, has led to the synthesis of thiophene analogues of chal-
cone and their subsequent heterocyclics. The thiophene
heteroaryl ring is important owing to elemental sulphur having
antifungal properties, while chalcones bearing sulphur either
as a thiophene or as a side chain (thiomethyl group) have been
reported to exhibit biological activities such as antimicrobial,
antibacterial, antifungal (Tran et al., 2012; Ranganathan
et al., 2012) and anti-tumour (Rizvi et al., 2012).
Herein, the synthesis of 2-thienylchalcones as intermediates
towards ﬂavans, 6H-benzo[c]chromen-6-ones, tetrahydro-2H-
chromens, tetrahydroquinolines and diazepines is reported.
The new heterocyclic compounds’ chemical structures were
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were screened for antimicrobial activities against Staphylococcus
aureus, Escherichia coli, Bacillus subtilis, Pseudomonas
aeruginosa and Candida albicans.
2. Material and methods
2.1. General methods
Melting points were determined on a Stuart melting point
apparatus SMP1 (UK) and are uncorrected. Infrared spectra
were recorded neat on a Perkin Elmer FT-IR spectrophotom-
eter 1000. 1H, 13C and 2D-NMR spectra were recorded on a
Bruker Avance DPX 300 MHz NMR spectrometer in CDCl3
(or acetone-d6) with TMS as an internal standard at room tem-
perature. Electron impact (EI) High resolution mass spectra
(HR-MS) were carried out on GCT Premier Mass Spectrome-
ter (Waters) ionisation energy 70 eV, at the Chemistry Depart-
ment, University of Botswana. All reactions were monitored
by TLC, which was carried out on 0.25 mm layer of Merck sil-
ica gel 60 F254 pre-coated on aluminium sheets. Laboratory
grade chemicals and solvents available commercially in high
purity were used. All the prepared compounds were identiﬁed
by physical properties, IR, HRMS and NMR data. Yields
reported are isolated yields unless indicated otherwise.
2.1.1. General procedure for the synthesis of thiophen-2-yl-
chalcones (1a–d)
Chalcones, 1a and 1b were prepared using the solvent-free
green protocol of hand grinding (Dev and Dhaneshwar,
2013; ZiXing et al., 2010), while conventional base-catalysed
Claisen–Schmidt condensation was used for the synthesis of
chalcones 1c and 1d (Mazimba et al., 2011).
2.1.1.1. (E)-3-(2-Hydroxyphenyl)-1-(thiophen-2-yl)prop-2-en-
1-one (1a). Yellow solid; m.p.; 156–158 C; Yield 87%; IR
(neat, cm1): 3326 (OH), 3095 (‚CAH), 1692 (C‚O), 1666
(C‚O), 2922 (CAH), 1233, 1176 (CAO), 1558, 1456, 750
(Aromatic); 1H-NMR (CDCl3, 300 MHz) d: 6.98 (3H, m, H-
3, 4 & 5), 7.23 (1H, dd, J= 1.2, 3.6 Hz, H-40), 7.61 (1H, d,
J= 15.6 Hz, Ha), 7.63 (1H, dd, J= 1.5, 8.1 Hz, H-6), 7.72
(1H, dd, J= 1.2, 4.5 Hz, H-50), 7.93 (1H, dd, J= 0.9,
3.6 Hz, H-30), 8.29 (1H, d, J= 15.6 Hz, Hb);
13C-NMR
(75 MHz, CDCl3) d: 116.1 (C-3), 119.9 (C-5), 121.2 (Ca),
121.8 (C-1), 128.4 (C-6), 128.9 (C-40), 131.8 (C-4), 132.0 (C-
30), 134.0 (C-50), 138.7 (Cb), 146.2 (C-10), 156.9 (C-2), 181.7
(C‚O); HRMS (EI, 70 eV): found m/z 230.0402 [M+], mol.
formula C13H10O2S, needing 230.0402.
2.1.1.2. (E)-3-(2-Hydroxy-3-methoxyphenyl)-1-(thiophen-
2-yl)prop-2-en-1-one (1b).White solid; m.p.; 156–158 C; yield
85%; IR (neat, cm1): 3325 (OH), 3096 (‚CAH), 2922
(CAH), 1664 (C‚O), 1224, 1088 (CAOAC), 1558, 1457, 755
(Aromatic); 1H-NMR (CDCl3, 300 MHz) d: 3.54 (3H, s,
3-OCH3), 6.68 (1H, t, J= 8.1 Hz, H-4), 7.07 (1H, dd,
J= 1.2, 7.8 Hz, H-5), 7.29 (1H, dd, J= 0.9, 3.9 Hz, H-40),
7.41 (1H, dd, J= 1.2, 7.8 Hz, H-6), 7.79 (1H, d,
J= 15.6 Hz, Ha), 7.93 (1H, dd, J= 1.2, 4.8 Hz, H-4
0), 8.12
(1H, dd, J= 0.9, 3.6 Hz, H-30), 8.19 (1H, d, J= 15.6 Hz,
Hb);
13C-NMR (75 MHz, CDCl3) d: 55.9 (3-OCH3). 112.9
(C-4), 119.3 (C-6), 120.2 (C-5), 121.3 (C-1), 121.5 (Ca), 128.4(C-40), 132.0 (C-30), 134.0 (C-50), 138.4 (Cb), 146.2 (C-10),
146.7 (C-2), 147.8 (C-3), 181.7 (C‚O); HRMS (EI, 70 eV):
found m/z 260.0507 [M+], mol. formula C14H12O3S, needing
260.0507.
2.1.1.3. (E)-3-Phenyl-1-(thiophen-2-yl)prop-2-en-1-one (1c).
White solid; m.p.; 90–92 C; yield 87%; IR (neat, cm1): 3082
(‚CAH), 2948, 2863 (CAH), 1660 (C‚O); 1H-NMR (CDCl3,
300 MHz) d: 7.23 (1H, t, J= 5.4 Hz, H-40), 7.44 (1H, m, H-4),
7.46 (2H, m, H-3 & 5), 7.47 (1H, d, J= 15.0 Hz, Ha), 7.69 (2H,
m, H-2 & 6), 7.73 (1H, dd, J= 0.9, 4.8 Hz, H-50), 7.88 (1H, d,
J= 15.0 Hz, Hb), 7.93 (1H, dd, J= 3.3, 4.2 Hz, H-3
0); 13C-
NMR (75 MHz, CDCl3) d: 121.6 (Ca), 128.2 (C-4), 128.5 (C-3
& 5), 129.0 (C-2 & 6), 134.7 (C-1), 130.6 (C-40), 131.9 (C-50),
133.9 (C-30), 144.1 (Cb), 145.5 (C-10), 182.0 (C‚O); HRMS
(EI, 70 eV): found m/z 214.0452 [M+], mol. formula
C13H10OS, needing 214.0452.
2.1.1.4. (E)-3-(4-Methoxyphenyl)-1-(thiophen-2-yl)prop-2-en-
1-one (1d). Yellow solid; m.p.; 108–110 C; yield 84%; IR
(neat, cm1): 3088 (‚CAH), 2945, 2860 (CAH), 1659
(C‚O), 1245, 1031 (CAO), 1510, 1416, 755 (Aromatic); 1H-
NMR (CDCl3, 300 MHz) d: 3.91 (3H, s, 4-OCH3), 7.03 (2H,
dd, J= 8.4 Hz, H-3 & 5), 7.44 (2H, d, J= 8.4 Hz, H-2 & 6),
7.62 (1H, t, J= 5.0 Hz, H-40), 7.71 (1H, dd, J= 0.9, 4.3 Hz,
H-50), 7.82 (1H, dd, J= 3.3, 4.5 Hz, H-30), 7.90 (1H, d,
J= 15.9 Hz, Ha), 8.23 (1H, d, J= 15.9 Hz, Hb);
13C-NMR
(75 MHz, CDCl3) d: 54.8 (4-OCH3), 116.2 (C-3 & 5), 121.6
(Ca), 122.0 (C-1), 128.9 (C-2 & 6), 129.7 (C-3
0), 131.7 (C-50),
133.4 (C-40), 140.0 (Cb), 157.0 (C-10), 160.0 (C-4), 189.2
(C‚O); HRMS (EI, 70 eV): found m/z 244.0558 [M+], mol.
formula C14H12O2S, needing 244.0558.
2.1.2. General procedure for the synthesis of ﬂavans (2a,b)
To a methanolic solution of chalcone (10 mmol) at 20 C
sodium borohydride powder (50 mmol) was introduced slowly
over 20 min. The reaction was quenched with 2 M HCl in an
ice bath. The organic layer was extracted with ethyl acetate,
dried over magnesium sulphate and concentrated to a residue.
To this residue glacial acetic acid (15 ml) was added and reﬂuxed
for 20 min. The organic layer was treated as above and
after puriﬁcation using ﬂash column chromatography using
n-hexane–ethylacetate (5:1, v/v) a pure product was obtained.
2.1.2.1. 2-(Thiophen-2-yl)chroman (2a). Brown gum; yield
70%; IR (neat, cm1): 3179 (‚CAH), 2931, 2880 (CAH),
1239, 1167 (CAOAC), 1595, 1456, 755 (Aromatic); 1H-NMR
(CDCl3, 300 MHz) d: 2.31 & 2.40 (each 1H, m, H-3a & 3b),
2.95 & 3.04 (each 1H, m, H-4a & 4b), 5.40 (1H, dd, J= 2.4,
9.6 Hz, H-2), 6.98 (2H, m, H-6 & 8), 7.09 (1H, dd, J= 1.5,
4.8 Hz, H-50), 7.17 (2H, m, H-5 & 7), 7.23 (1H, dd, J= 1.2,
4.2 Hz, H-40), 7.37 (1H, dd, J= 0.9, 5.1 Hz, H-30); 13C-NMR
(75 MHz, CDCl3) d: 24.8 (C-4), 29.8 (C-3), 73.7 (C-2), 117.1
(C-8), 120.6 (C-6), 121.6 (C-4a), 124.5 (C-30), 125.1 (C-50),
126.7 (C-40), 127.4 (C-7), 129.6 (C-5), 144.8 (C-10), 154.6
(C-8a); HRMS (EI, 70 eV): found m/z 216.0604 [M+], mol.
formula C13H12OS, needing 216.0604.
2.1.2.2. 8-Methoxy-2-(thiophen-2-yl)chroman (2b). Brown
gum; yield 65%; IR (neat, cm1): 3108 (‚CAH), 2951, 2850
(CAH), 1230, 1182, 1110 (CAOAC), 1581, 1487, 749
(Aromatic); 1H-NMR (CDCl3, 300 MHz) d: 3.53 (3H, s,
44 O. Mazimba8-OCH3) 2.75 & 2.82 (each 1H, m, H-3a & 3b), 2.99 & 3.01
(each 1H, m, H-4a & 4b), 4.90 (1H, dd, J= 3.9, 9.3 Hz,
H-2), 6.90–6.98 (3H, m, H-5, 6 & 7), 7.13–7.18 (2H, m, H-40
& 50), 7.28 (1H, dd, J= 0.9, 3.6 Hz, H-30); 13C-NMR
(75 MHz, CDCl3) d: 29.9 (C-4), 39.4 (C-3), 45.6 (8-OCH3),
68.7 (C-2), 116.1 (C-7), 120.9 (C-5), 124.1 (C-6), 124.8 (C-30),
126.7 (C-50), 127.7 (C-40), 130.6 (C-4a), 147.6 (C-8a), 144.7
(C-10), 154.3 (C-7); HRMS (EI, 70 eV): found m/z 246.0708
[M+], mol. formula C14H14O2S, needing 246.0715.
2.1.3. General procedure for synthesis of 6H-benzo[c]chromen-
6-one (4a,b)
Thiophen-2-yl-chalcones (1a or 1b) (2 mmol), potassium car-
bonate powder (20 mol%) and ethylacetoacetate (2 mmol)
were taken in ethanol and stirred at 60 C for 30 min. Then
the reaction mixture was cooled and poured into cold water.
The precipitated solid was collected by ﬁltration and recrystal-
lized in ethanol.
2.1.3.1. 7-Hydroxy-9-(thiophen-2-yl)-6H-benzo[c]chromen-6-
one (4a). White solid; m.p.; 163–165 C; yield 60%; IR (neat,
cm1): 3105 (‚CAH), 2974, 2860 (CAH), 1676 (C‚O), 1276,
1208, 1108 (CAOAC), 1564, 1410, 851 (Aromatic); 1H-NMR
(CDCl3, 300 MHz) d: 7.22 (1H, dd, J= 1.5, 3.6 Hz, H-40),
7.35 (1H, d, J= 1.5 Hz, H-8), 7.41 (1H, dd, J= 1.2, 8.1 Hz,
H-4), 7.46 (1H, dd, J= 1.2, 8.1 Hz, H-2), 7.51 (1H, dd,
J= 1.2, 5.1 Hz, H-30), 7.54 (1H, dd, J= 1.8, 7.5 Hz, H-3),
7.59 (1H, dd, J= 1.2, 3.6 Hz, H-50), 7.81 (1H, d, J= 1.5 Hz,
H-10), 8.14 (1H, dd, J= 1.8, 7.8 Hz, H-1), 11.4 (1H, s,
7-OH); 13C-NMR (75 MHz, CDCl3) d: 104.8 (C-6a), 109.4
(C-8), 113.0 (C-10), 117.0 (C-4), 118.1 (C-10b), 123.3 (C-2),
125.2 (C-30), 125.8 (C-50), 127.6 (C-40), 128.5 (C-3), 130.8
(C-1), 135.7 (C-10a), 142.3 (C-10), 142.9 (C-9), 150.8 (C-4a),
162.7 (C-6), 165.1 (C-7); HRMS (EI, 70 eV): found m/z
294.0351 [M+], mol. formula C17H10O3S, needing 294.0351.
2.1.3.2. 7-Hydroxy-4-methoxy-9-(thiophen-2-yl)-6H-benzo[c]
chromen-6-one (4b). White solid; m.p.; 148–150 C; yield
52%; IR (neat, cm1): 3130 (‚CAH), 2952, 2850 (CAH),
1678 (C‚O), 1271, 1268 (CAOAC), 1556, 1407, 817
(Aromatic); 1H-NMR (CDCl3, 300 MHz) d: 3.57 (3H, s,
4-OCH3), 6.84 (1H, dd, J= 0.9, 7.8 Hz, H-3), 7.14 (1H, dd,
J= 1.5, 3.6 Hz, H-40), 7.27 (1H, dd, J= 1.2, 7.8 Hz, H-2),
7.33 (1H, d, J= 1.5 Hz, H-8), 7.42 (1H, dd, J= 1.5, 3.6 Hz,
H-30), 7.92 (1H, dd, J= 1.2, 3.6 Hz, H-3), 7.99 (1H, dd,
J= 1.2, 7.8 Hz, H-1), 8.12 (1H, d, J= 1.5 Hz, H-10), 12.6
(1H, s, 7-OH); 13C-NMR (75 MHz, CDCl3) d: 55.7 (4-OMe),
105.7 (C-6a), 108.4 (C-8), 111.3 (C-10), 113.0 (C-3), 119.4
(C-1), 121.2 (C-10b), 121.9 (C-2), 127.5 (C-50), 127.9 (C-30),
128.0 (C-40), 134.4 (C-10a), 140.0 (C-10), 140.3 (C-9), 148.1
(C-4a), 150.0 (C-4), 161.9 (C-6), 165.2 (C-7); HRMS (EI,
70 eV): found m/z 324.0456 [M+], mol. formula C18H12O4S,
needing 324.0456.
2.1.4. General procedure for synthesis of tetrahydroquinolines
(7a,b)
A mixture of chalcones (1c or 1d) (1 mmol), cyclohexanone
(2 mmol) and NaOH (2 mmol) were ground with an agate
mortar and a pestle for 25 min until the reaction mixture
became a solid. The solid was dissolved in acetone (10 mL)
and cold water was added (20 mL). The separated solid wascollected by ﬁltration, washed with water and ethanol. The
1,5-diketone (1 mmol) and ammonium acetate (5 mmol) in gla-
cial acetic acid (20 mL) were heated to reﬂux (30 min). The
crude product was precipitated out of solution by the addition
of cold water (10 mL), collected and washed with water and
ethanol.
2.1.4.1. 5,6,7,8-Tetrahydro-4-phenyl-2-(thiophen-2-yl)quinoline
(7a). Brown solid; m.p.; 175–177 C; yield 90%; IR (neat,
cm1): 3057 (‚CAH), 2928, 2854 (CAH), 1655, 1544 (pyri-
dine ring), 1584, 1453, 853 (Aromatic); 1H-NMR (CDCl3,
300 MHz) d: 1.66 (2H, m, H-6), 1.82 (2H, m, H-7), 2.52 (2H,
m, H-5), 2.94 (2H, t, J= 4.5 Hz, H-8), 6.96 (1H, m, H-40),
6.98 (1H, m, H-400), 7.22 (2H, m, H-200 & 600), 7.25 (1H, s, H-
3), 7.31 (1H, m, H-50), 7.34 (2H, m, H-300 & 500), 7.45 (1H,
dd, J= 0.9, 3.6 Hz, H-30); 13C-NMR (75 MHz, CDCl3) d:
23.0 (C-7), 27.3 (C-6), 29.7 (C-5), 33.1 (C-8), 117.6 (C-3),
124.1 (C-30), 127.6 (C-40), 127.8 (C-4a), 128.0 (C-50), 128.4
(C-200 & 600), 128.5 (C-300 & 500), 128.6 (C-400), 139.5 (C-100),
145.1 (C-10), 149.3 (C-4), 150.3 (C-2), 157.2 (C-8a); HRMS
(EI, 70 eV): found m/z 291.1080 [M+], mol. formula
C19H17NS, needing 291.1082.
2.1.4.2. 5,6,7,8-Tetrahydro-4-(4-methoxyphenyl)-2-(thiophen-
2-yl)quinoline (7b). Brown solid, m.p.; 212–214 C; yield
90%; IR (neat, cm1): 3025 (‚CAH), 2931, 2860 (CAH),
1658, 1537 (pyridine ring), 1515, 1450, 834 (Aromatic);
1H-NMR (CDCl3, 300 MHz) d: 1.82 (2H, m, H-7), 1.93 (2H,
m, H-6), 2.68 (2H, m, H-5), 3.07 (2H, t, J= 6.6 Hz, H-8),
3.91 (3H, s, 400-OCH3), 7.04 (2H, d, J= 8.4 Hz, H-300 & 500),
7.12 (2H, dd, J= 1.2, 3.6 Hz, H-40 & 50), 7.33 (2H, d,
J= 8.4 Hz, H-200 & 600), 7.37 (1H, s, H-3), 7.56 (1H, d,
J= 3.6 Hz, H-30); 13C-NMR (75 MHz, CDCl3) d: 23.1 (C-7),
27.4 (C-6), 29.7 (C-5), 33.1 (C-8), 55.3 (400-OCH3), 113.8 (C-300
& 500), 117.7 (C-3), 124.0 (C-30), 127.8 (C-30 & 40), 129.0 (C-200
& 600), 129.1 (C-4), 131.7 (C-4a), 145.2 (C-10), 149.3 (C-2),
149.9 (C-4), 157.6 (C-8a), 159.3 (C-40); HRMS (EI, 70 eV):
found m/z 321.1185 [M+], mol. formula C20H19NOS, needing
321.1187.
2.1.5. General procedure for synthesis of 5-oxotetrahydro-2H-
chromenes
To a methanolic solution of the 1,5-diketone (1 mmol) sodium
borohydride powder (5 mol) was added over 10 min. Then
cold 2 M HCl was added. The organic layer was extracted with
chloroform, dried over magnesium sulphate and concentrated
to a residue. The residue was taken in glacial acetic acid (10 ml)
and reﬂuxed for 30 min. The organic layer was extracted using
ethyl acetate and dried over magnesium sulphate. After being
concentrated it was puriﬁed using ﬂash column chromatogra-
phy eluted by petroleum ether-ethylacetate (v/v, 4:1) to obtain
a pure product.
2.1.5.1. Octahydro-4-phenyl-2-(thiophen-2-yl)-2H-chromene
(9a). White gum; yield 85%; IR (neat, cm1): 3059 (‚CAH),
2923, 2856 (CAH), 1598, 1450, 757 (Aromatic), 1239, 1077
(CAO); 1H-NMR (CDCl3, 300 MHz) d: 1.17–1.87 (8H, m,
H-5, 6, 7 & 8), 2.05 (1H, dt, J= 2.4, 9.0 Hz, H-4a), 2.17
(2H, m, H-3), 3.09 (1H, dt, J= 3.3, 12.3 Hz, H-4), 4.06 (1H,
q, J= 2.4, 12.3 Hz, H-8a), 5.05 (1H, dd, J= 2.8, 8.4 Hz,
H-2), 6.83 (1H, m, H-40) 6.86 (1H, m, H-30), 7.10 (1H, m,
S
O OH
S
O OH
S
O
S
O
c
a b
d
OMe
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Figure 1 Structures of thienylchalcones.
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m, H-300 & 500); 13C-NMR (75 MHz, CDCl3) d: 20.3 (C-7), 25.4
(C-5), 25.5 (C-6), 26.8 (C-8), 39.3 (C-4), 40.4 (C-3), 42.8 (C-4a),
68.4 (C-2), 76.5 (C-8a), 123.2 (C-30), 124.3 (C-50), 126.4 (C-400),
126.5 (C-40), 127.5 (C-200 & 600), 128.6 (C-300 & 500), 143.9 (C-100),
146.4 (C-10); HRMS (EI, 70 eV): found m/z 298.1391 [M+],
mol. formula C19H22OS, needing 298.1391.
2.1.5.2. Octahydro-4-(4-methoxyphenyl)-2-(thiophen-2-yl)-2H-
chromene (9b). Brown gum; yield 86%; IR (neat, cm1): 3025
(‚CAH), 2923, 2857 (CAH), 1510, 1444 (Aromatic), 1240,
1171 (CAO); 1H-NMR (CDCl3, 300 MHz) d: 1.19–1.99 (8H,
m, H-5, 6, 7 & 8), 2.04 (1H, dt, J= 3.9, 11.4 Hz, H-4a), 2.17
(2H, m, H-3), 3.05 (1H, dt, J= 3.3, 7.5 Hz, H-4), 3.68 (3H,
s, 400-OCH3), 4.05 (1H, q, J= 3.9, 7.5 Hz, H-8a), 5.01 (1H,
dd, J= 2.1, 11.4 Hz, H-2), 6.78 (2H, d, J= 8.4 Hz, H-300 &
500), 6.85 (2H, brs, H-40 & 50), 7.06 (2H, d, J= 8.4 Hz, H-200
& 600), 7.11 (1H, dd, J= 1.8, 4.8 Hz, H-30); 13C-NMR
(75 MHz, CDCl3) d: 20.3 (C-7), 25.4 (C-5), 26.8 (C-6), 29.7
(C-8), 38.4 (C-4), 40.7 (C-3), 43.1 (C-4a), 55.2 (400-OCH3),
68.4 (C-2), 76.5 (C-8a), 114.0 (C-300 & 500), 123.2 (C-30), 124.3
(C-50), 126.4 (C-40), 128.3 (C-200 & 600), 135.8 (C-100), 146.8
(C-10), 158.2 (C-400); HRMS (EI, 70 eV): found m/z 328.1500
[M+], mol. formula C20H24O2S, needing 328.1497.
2.1.6. General procedure for the preparation of diazepine
(10a,b)
A mixture of 1,5-diketone (10 mmol) and hydrazine hydrate
(10 mmol) in glacial acetic acid (20 mL) was reﬂuxed for 3 h.
The reaction mixture was cooled and poured into ice-cold
water. The precipitate formed was collected by ﬁltration and
recrystallized from ethanol.
2.1.6.1. 5-Phenyl-3-(thiophen-2-yl)-5,5a,6,7,8,9-hexahydro-4H-
benzo[c][1,2]diazepine (10a). White solid; m.p.; 126–128 C;
yield 66 %; IR (neat, cm1): 2931, 2854, (CH), 1607 (C‚N),
1510, 1450 (Aromatic); 1H-NMR (CDCl3, 300 MHz) d: 1.14–
1.78 (8H, m, H-6, 7, 8 & 9), 2.05–2.17 (2H, m, H-4), 2.24
(1H, m, H-5a), 2.34 (1H, m, H-5), 6.72–6.84 (5H, m, H-200,
300, 400, 500 & 600), 6.98 (1H, t, J= 3.1 H-40), 7.12 (1H, dd,
J= 2.4, 3.8 Hz, H-50), 7.15 (1H, dd, J= 1.5, 6.0 Hz, H-30);
13C-NMR (75 MHz, CDCl3) d: 24.9 (C-7), 26.0 (C-8), 28.9
(C-6), 33.7 (C-9), 43.8 (C-4), 42.1 (C-5), 46.9 (C-5a), 125.0
(C-30), 126.0 (C-400), 126.6 (C-40), 126.9 (C-50), 127.6 (C-10),
135.0 (C-100), 128.8 (C-200 & 600), 129.2 (C-300 & 500), 157.9 (C-
3), 158.0 (C-9a); HRMS (EI, 70 eV): found m/z 308.1350
[M+], mol. formula C19H20N2S, needing 308.1347.
2.1.6.2. 5-(4-Methoxyphenyl)-3-(thiophen-2-yl)-5,5a,6,7,8,9-
hexahydro-4H-benzo[c] [1,2]diazepine (10b). White solid,
m.p; 126–128 C; yield 68 %; IR (neat, cm1): 2930, 2856
(CH), 1610 (C‚N), 1570, 1458 (Aromatic); 1H-NMR (CDCl3,
300 MHz) d: 1.16–1.82 (8H, m, H-6, 7, 8 & 9), 2.29 (2H, m, H-
4), 2.54 (1H, t, J= 6.6 Hz, H-5a), 2.99 (1H, t, J= 6.0 Hz, H-
5), 3.54 (3H, s, 400-OCH3), 6.94 (2H, d, J= 8.4 Hz, H-300 & 500),
7.09 (1H, t, J= 2.4 Hz, H-40), 7.13 (1H, dd, J= 1.2, 2.4 Hz,
H-50), 7.22 (2H, d, J= 8.4 Hz, H-200 & 600), 7.31 (1H, dd,
J= 1.5, 5.4 Hz, H-30); 13C-NMR (75 MHz, CDCl3) d: 21.9
(C-7), 23.0 (C-8), 29.1 (C-6), 33.4 (C-9), 39.1 (C-4), 42.3
(C-5), 43.1 (C-5a), 60.0 (400-OCH3), 118.0 (C-300 & 500), 124.1
(C-10), 125.6 (C-30), 127.8 (C-40), 127.9 (C-50), 128.4 (C-200 &
600), 134.9 (C-100), 159.8 (C-400), 168.7 (C-9a & C-3); HRMS(EI, 70 eV): found m/z 338.1461 [M+], mol. formula C20H22
N2OS, needing 338.1453.
2.2. Antimicrobial activity
The synthesized compounds were tested in vitro for their anti-
bacterial and antifungal proﬁle using Dilution Method
(Ragavan et al., 2010; Danielle, 2006) against S. aureus (ATCC
9144), E. coli (ATCC 11229), B. subtilis (ATCC 6633),
P. aeruginosa (NCTC 10332) and C. albicans (ATCC 10231).
The test microorganisms were obtained from the Department
of Biological Sciences, University of Botswana. Ciproﬂoxacin
and Fluconazole were used as standards for bacteria and fungi
respectively. The tested solutions were serially diluted to give
concentrations of 5, 2.5, 1.25, 0.625 and 0.313 mg/mL. All tests
were done in triplicate. The antimicrobial activity was
expressed as minimum inhibitory concentration (MIC) of sam-
ple that prevented the visible growth of a microorganism.
3. Result and discussions
Initially, the synthesis of trans-2-thienylchalcones was
attempted using the efﬁcient, economical and a green protocol
of grinding the reactants together in the presence of catalytic
amount of sodium hydroxide. This method worked only for
chalcones devoid of hydroxyl groups (1c–d, 90% yield) while
grinding 2-hydroxybenzaldehydes did not afford chalcones.
The presence of hydroxyl groups on aryl aldehydes or ketones
is a limiting factor for the green protocol of chalcone synthesis.
Literature survey shows solvent-free synthesis of chalcones and
heterocyclic analogous of chalcones that excludes hydroxyl
groups as substituents (Dev and Dhaneshwar, 2013; ZiXing
et al., 2010; Rateb and Hussein, 2009). Hence, the conven-
tional base-catalysed Claisen–Schmidt condensation reaction
was adopted (Mazimba et al., 2011) and the thiophene chal-
cone analogues (1a–d) were obtained in 84–87% yields. The
thienyl chalcones have been previously reported in good yields
(81–90%) using the base catalysed condensation method
(Roman, 2004; Tran et al., 2012; Yin et al., 2012), the literature
spectroscopic data were also used to conﬁrm the identity of
reported chalcones. Next, the chalcones (Fig. 1) were used
for the synthesis of the desired heterocyclic compounds.
3.1. Synthesis of ﬂavans
Flavans (2-(thiophen-2-yl)chroman, 2a,b) were derived by the
reduction of the a,b-unsaturated ketone function of the chal-
cones (1a,b) using NaBH4. The ring closure to form a chroman
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46 O. Mazimbaring was achieved by reﬂuxing the resulting 2-(3-hydroxy-3-
(thiophen-2-yl)propyl)phenol (2c) in glacial acetic acid
(Scheme 1) as previously described (Mazimba et al., 2011).
The substitution of the chalcone benzene ring with the electron
rich thiophene ring did not affect the reaction path but resulted
in reduced yields. The 2-phenylchroman yield was 88%
(Mazimba et al., 2011) while the yield for 2-thiophenylchro-
man (2a) was found to be 70%. The electron donating
MeO-group led to the corresponding ﬂavan (2b) in 65% yields.
3.2. Synthesis of 7-hydroxy-9-(thiophen-2-yl)-6H-
benzo[c]chromen-6-ones
It is well reported that the reaction of chalcones with ethylace-
toacetate affords cyclohexanones (Samshuddin et al., 2012;
Roman, 2004), while the Knoevenagel reaction affords
coumarins from the condensation of ethylacetoacetate with
2-hydroxybenzaldehydes (Sashidhara et al., 2010). Therefore,
it was expected that 2-hydroxy-20-thienylchalcones would react
with ethylacetoacetate to furnish a 6H-benzo[c]chromene-
6,7(6aH)-dione (4c) ring system. But the product of the reaction
that was assisted by K2CO3, was identiﬁed to be 6H-benzo
[c]chromen-6-ones (4a,b) instead of the expected 9-(thiophen-
2-yl)-10,10a-dihydro-6H-benzo[c]chromene-6,7(6aH)-dione (4c),
Scheme 2. The reaction is thought to proceed by the Michael
addition of ethylacetoacetate to chalcone, followed by the ring
forming intramolecular Aldol condensation of the ester methyl
group with the chalcone keto-group to form cyclohexenones
(Roman, 2004). The presence of 20-OH enables a trans-
esteriﬁcation reaction to form intermediate 4c, which undergoes
oxidative aromatization to form 6H-benzo[c]chromen-6-ones
(4a,b).
3.3. Synthesis of tetrahydroquinolines
2,4-Diaryltetrahydroquinolines were targeted owing to their
pharmacological activities (Chabert et al., 2006) and ease of
the availability of 1,5-diketones from chalcones. The required
1,5-diketones (6a–b) were obtained via the green protocol
involving the Michael addition of cyclohexanone (5) to
chalcones (1c,d) under solventless conditions. The reaction
exclusively affords a single Michael addition product due to
the unfavourable intramolecular self-condensation of the 1,
5-diketones (ZiXing et al., 2010). Treatment of 1,5-diketones
with ammonium acetate in acetic acid (Scheme 3) yieldedS
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R
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Scheme 1 Synthesis of thienylchalcones and ﬂavans.tetrahydroquinolines (7a,b) in good yields, 90%. This green
protocol is an efﬁcient ‘1 + 5’ strategy that involves double
condensation of an amino group with 1,5-diketones to afford
six membered ring 1,4-dihydropyridine (4-phenyl-2-(thiophen-
2-yl)-1,4,5,6,7,8-hexahydroquinoline, 7c). The 1,4-dihydropyri-
dine is subsequently oxidised to 4-phenyl-2-(thiophen-2-yl)-5,
6,7,8-tetrahydroquinoline, Scheme 3 (Gezegen et al., 2010).
The quinolyl ring singlet proton NMR signal (7.25 ppm) was
diagnostic.
3.4. Synthesis of 5-oxotetrahydro-2H-chromenes
The strategy towards 2H-chromene involved the reduction of
1,5-diketones (6a,b) using NaBH4 followed by the cyclization+
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Antimicrobial activities of heterocycles derived from thienylchalcones 47of the resulting 1,5-diols (8a,8b) in glacial acetic acid which
afforded 5-oxotetrahydro-2H-chromenes (9a,b) (Scheme 4).
The heterocyclization of 1,5-diketones has been reported under
CF3CO2H/PtCl2–H2 at 200 C, Rh/C-H2, Raney Nickel–
AcOH at 150 C (Kharchenko et al., 2000) and TiCl4–Et3N
(Sergeeva et al., 2010). The reported reactions were carried
out at elevated temperatures and suffered from low yields
(34–50%), but the current protocol offers higher yields (85–
86%) and operational simplicity.Table 1 Antimicrobial activity of thiophen-2-yl-chalcone derived h
Compound Minimum inhibitory concentration (MIC; m
S. aureus E. coli
2a 1.25 1.25
2b 1.25 1.25
4a 0.625 0.625
4b 0.625 0.625
7a 0.625 0.625
7b 0.625 0.625
9a 1.25 2.5
9b 1.25 1.25
10a 0.313 0.625
10b 0.313 0.625
Ciproﬂoxacin 0.625 0.625
Fluconazole – –3.5. Synthesis of diazepines
The condensation reaction between amines and ketones is
known to yield imines or Schiff bases (Shaikh et al., 2013).
Thus, 1,5-diketones bears a good synthon for heterocyclization
reactions with N-nucleophiles to form six or seven membered
rings. This conventional reaction was applied to obtain diaze-
pines (10a,b, Scheme 5) from the reaction of hydrazine hydrate
with 1,5-diketones (6a,b) derived from 2-thienylchalcone. The
reaction was found to be simple and short affording moderate
yields (66–68%) and a single product. The synthesis and phar-
macological importance of diazepines are widely reported
(Samshuddin et al., 2012; Luszczki, 2009; Rodriguez et al.,
2004).
4. Antimicrobial studies
The synthesized new heterocyclic compounds were tested
in vitro for their antimicrobial proﬁle using the dilution
method (Ragavan et al., 2010; Danielle, 2006) against
S. aureus, E. coli, B. subtilis, P. aeruginosa and C. albicans.
The tested compounds showed moderate to good antibacterial
and antifungal activities. 6H-benzo[c]chromen-6-ones (4a,b)
show good activities (0.625 mg/mL) against both bacteria
and fungi, and the conjugation of hydroxy and ester groups
may favour the uptake of these compounds by microbial cells.
Tetrahydroquinolines (7a,b) and diazepines’ (10a,b) excellent
(0.313 mg/mL) results show the importance of the carbon–
nitrogen bond in biological systems (Yadav and Purohit,
2013). The presence of the MeO-group does not seem to have
a signiﬁcant effect on the activities of compounds 7a,b and
10a,b, Table 1. These activities are in comparison with other
reports which show antimicrobial activities for these N-con-
taining compounds (Samshuddin et al., 2012; Dodiya et al.,
2011). Flavans (2a,b) and 5-oxotetrahydro-2H-chromenes
(9a,b) indicate moderate (1.25 mg/mL) activities. The data on
antimicrobial activities of the target compounds are given in
Table 1.
5. Conclusion
Thiophene analogues of chalcone (1a–d) were synthesized in
good yields. 1,5-diketones were obtained utilising greeneterocyclic compounds.
g/mL)
B. subtilis P. aeruginosa C. albicans
1.25 1.25 0.625
1.25 1.25 1.25
0.625 0.625 0.625
0.625 0.625 0.625
0.625 0.313 0.625
0.625 0.313 0.625
1.25 1.25 2.5
1.25 1.25 1.25
0.625 0.313 0.313
0.625 0.313 0.313
0.625 0.625 –
– – 0.625
48 O. MazimbaMichael addition of cyclohexanone to 2-thienylchalcones
devoid of hydroxyl groups. The chalcones and 1,5-diketones
were a good synthon for the synthesis of heterocyclic
compounds, shown here by the synthesis of new ﬂavans,
6H-benzo[c]chromen-6-ones, tetrahydro-2H-chromens, tetra-
hydroquinolines, and diazepines. The methods utilised were
short and efﬁcient in good yields and operational simplicity.
The heterocyclic compounds were screened for their antimicro-
bial activity against S. aureus, E. coli, B. subtilis, P. aeruginosa
and C. albicans, showing moderate to good antibacterial and
antifungal activities. Diazepines (10a,b) exhibited excellent
antibacterial (S. aureus and P. aeruginosa) and antifungal (C.
albicans) activities. The preliminary data on the antimicrobial
activities of the new scaffolds should serve as an indicator for
structural modulation to improve activities and explain the
structure activity relationships. The exhibition of chalcone syn-
thon potential and the antimicrobial activity of the target het-
erocyclic compounds validates the signiﬁcance of this study.
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